Russell Investments Group’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $94.5K | Sell |
27,795
-39,589
| -59% | -$135K | ﹤0.01% | 2832 |
|
2025
Q1 | $270K | Buy |
67,384
+39,582
| +142% | +$159K | ﹤0.01% | 2504 |
|
2024
Q4 | $180K | Sell |
27,802
-10,403
| -27% | -$67.5K | ﹤0.01% | 2563 |
|
2024
Q3 | $212K | Buy |
38,205
+29,845
| +357% | +$165K | ﹤0.01% | 2501 |
|
2024
Q2 | $46.6K | Buy |
8,360
+8,168
| +4,254% | +$45.6K | ﹤0.01% | 2778 |
|
2024
Q1 | $1.29K | Buy |
192
+71
| +59% | +$476 | ﹤0.01% | 3115 |
|
2023
Q4 | $1.1K | Buy |
+121
| New | +$1.1K | ﹤0.01% | 3054 |
|